Exemptia
Manufacturing · United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
United StatesWebsite
www.exemptia.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Exemptia
Zydus Cadila manufactures and promotes Exemptia, a potent TNF-inhibitor and anti-inflammatory drug in India. Exemptia is prescribed for various conditions including Rheumatoid Arthritis, Psoriatic Arthritis, and Juvenile Idiopathic Arthritis. The company aims to provide effective treatment options for patients suffering from autoimmune diseases. Zydus Cadila focuses on empowering healthcare professionals and patients with comprehensive information and support regarding their products.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Exemptia your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Check out if Exemptia is spiking on competitors!
Click to see if Exemptia had a recent Job posting/layoffs
Exemptia, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Exemptia launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Exemptia has new funding data
Check if Exemptia has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Exemptia recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Exemptia
Recommended Actions
Reach out to Masked Content who joined Exemptia as Masked Content
Find 3 more new buyers
Compare Similar Companies to Exemptia
Compare insights from companies similar to Exemptia, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Exemptia
<$5M
11-50
Private
-
-
N/A
Company Profile Activity
Activity Insights
Exemptia is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Exemptia is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Exemptia.
Exemptia Tech Stack
A closer look at the technologies used by Exemptia
See more technologies
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Exemptia
Sign Up For FreeTo access detailed company insights
Zydus Cadila manufactures and promotes Exemptia, a potent TNF-inhibitor and anti-inflammatory drug in India. Exemptia is prescribed for various conditions including Rheumatoid Arthritis, Psoriatic Arthritis, and Juvenile Idiopathic Arthritis. The company aims to provide effective treatment options for patients suffering from autoimmune diseases. Zy... Read More
